Anzeige
Mehr »
Dienstag, 13.01.2026 - Börsentäglich über 12.000 News
Gold auf Rekordhoch: Eine der spannendsten Gold-Stories 2026 steht ganz am Anfang
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
275 Leser
Artikel bewerten:
(1)

ActivePure Medical Announces Distribution Agreement with Southern Strategic Sourcing Partners (S3P)

Multi-Year Contract Offers Savings on Continuous Disinfection Products to S3P Members

DALLAS, TX / ACCESSWIRE / March 1, 2022 / ActivePure Medical, the exclusive healthcare provider of ActivePure Technology, announced its automated, whole-room disinfection products are now available to Southern Strategic Sourcing Partners (S3P) through its distribution agreement with American Medical Xchange, LLC (AMX), an NMSDC-certified minority-owned distribution company based in Longwood, Fla. AMX is a distributor of medical-surgical equipment and continuous, full-facility disinfection devices for healthcare organizations throughout the United States.

The U.S. Food and Drug Administration (FDA) cleared ActivePure Medical Guardian as a free-standing device used in professional healthcare environments to reduce airborne contaminants. ActivePure reduces the viability of microorganisms by 4-6 logs, such as Staphylococcus epidermidis and MS2 as tested and featured on the ActivePure Medical website.

The new Automated Room Disinfection agreement enables S3P members, which are in the Southeastern United States, to take advantage of special pricing and terms for the FDA-cleared ActivePure Medical Guardian and other continuous, full-facility, surface and air solutions.

"We are thrilled to announce AMX as our newest distribution partner for S3P members," said Dan Marsh, president of ActivePure Medical. "We have been impressed with CEO Alister Barrow's leadership since he founded AMX and look forward to working with him as we offer S3P members with the very best in facility-wide surface and air disinfection technology."

ActivePure Medical is an infection prevention company that offers a patented and proven disinfection technology that runs continuously and automatically to inactivate pathogens, including mold, bacteria and viruses known to cause healthcare-associated infections (HAIs) facility-wide. The technology has received over 130 patents with more than 70 in the United States and more than 60 internationally. All ActivePure Medical products are California Air and Resource Board (CARB) certified.

ActivePure Medical will be introduced to S3P Members as the official air sponsor of the S3P Clinical Supply Conference 2022 on March 2-3 at Hotel Effie Sandestin in Miramar Beach, Fla. ActivePure Medical will provide enough portable devices -- including the ActivePure Medical Guardian, ActivePure Medical Surface & Air Guardian and ActivePure Beyond Guardian -- to disinfect the air and surfaces across the entire event space. ActivePure's patented technology releases thousands of submicroscopic particles that actively target pathogens in the air and on surfaces, inactivating them on contact and turning them into harmless byproducts. In addition to outfitting the space with ActivePure Technology, the conference is requiring that all in-person attendees show proof of COVID-19 vaccination and follow state and local guidelines and recommendations by the Centers for Disease Control and Prevention (CDC.)

"Ensuring the air and surfaces of the conference are protected with ActivePure Medical's infection prevention technology is paramount for events like this one," Marsh said. He added that "providing additional measures goes hand-in-hand with our partnership with S3P and AMX."

"AMX is proud to bring ActivePure Medical products into our portfolio," Barrow said. "Our agreement with S3P provides its members with access to ActivePure Medical's FDA-cleared Class II Medical Devices, specifically designed for healthcare settings, along with other ActivePure Medical products like the HVAC induct units."

ActivePure is adaptable to current HVAC systems and precisely configured by engineers to any interior space, utilizing portable units and/or installed induct HVAC units. ActivePure works as an added layer of protection against harmful HAIs and is exceptionally effective against the SARS-CoV-2 virus, which easily transmits COVID-19 and its variants from person to person in enclosed spaces. Independent testing completed in FDA-compliant biosafety labs level three and four found that ActivePure inactivated more than 99.96% of a high concentration of SARS-CoV-2 virus in less than three minutes.

The new agreement is available on the S3P members portal. Additionally, members may request a free, customized consultation with AMX by emailing support@amx-llc.com.

To learn more about ActivePure Medical, its uses and scientific studies, please visit ActivePureMedical.com, or call 800-572-6241.

ABOUT ACTIVEPURE MEDICAL, LLC:
ActivePure Medical, the exclusive healthcare provider of ActivePure, was launched in 2020 after the ActivePure Medical Guardian received?Class II Medical Device clearance from the U.S. Food and Drug Administration (FDA). ActivePure designed these medical-grade, automated and continuous disinfection units to combat some of healthcare's most resistant pathogens that lead to healthcare-associated infections (HAIs.) The ActivePure powered units have been proven effective in extensive independent laboratory and healthcare settings and are available in portable and induct HVAC configurations. All ActivePure Medical units are California Air and Resource Board (CARB) certified to meet ozone and electrical safety standards and designed for use facility-wide without interrupting the continuum of care. For more information on ActivePure Medical, please visit ActivePureMedical.com or call 800-572-6241.

ABOUT AMERICAN MEDICAL XCHANGE, LLC:
American Medical Xchange is a Minority-Owned Distribution Company providing personal protective equipment and other medical devices to our healthcare partners throughout the United States. To learn more, visit americanmedx.com.

MEDIA CONTACTS:
Jo Trizila, TrizCom PR on behalf of ActivePure
Email: Jo@TrizCom.com
Office: 972-247-1369
Cell/Text: 214-232-0078

Or
Tonie Auer, TrizCom PR on behalf of ActivePure
Email: tonie@TrizCom.com
Office: 972-247-1369
Cell/Text: 817-925-2013

SOURCE: ActivePure Medical



View source version on accesswire.com:
https://www.accesswire.com/690932/ActivePure-Medical-Announces-Distribution-Agreement-with-Southern-Strategic-Sourcing-Partners-S3P

© 2022 ACCESS Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.